Loading...
Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors
Treatment of advanced, poorly immunogenic tumors in animal models, considered the closest simulation available thus far for conditions observed in cancer patients, remains a major challenge for cancer immunotherapy. We reported previously that established tumors in mice receiving an agonistic mAb to...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2002
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC150893/ https://ncbi.nlm.nih.gov/pubmed/11877473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI14184 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|